Loading...
Gene therapy for mucopolysaccharidosis
Mucopolysaccharidoses (MPS) are due to deficiencies in activities of lysosomal enzymes that degrade glycosaminoglycans. Some attempts at gene therapy for MPS in animal models have involved intravenous injection of vectors derived from an adeno-associated virus (AAV), adenovirus, retrovirus or a plas...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2007
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3340574/ https://ncbi.nlm.nih.gov/pubmed/17727324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.7.9.1333 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|